Latest / WTR Small-Cap Spotlight
Marizyme Inc. (MRZM) with David Barthel and Matt Borsch
Send us Fan Mail
Marizyme, Inc. CEO David Barthel joins WTR’s Tim Regan and Matt Borsch to provide an introduction to Marizyme, a fast-growing biomedical company engaged in the accelerated development and commercialization of products from its multi-technology platform. A key focus for our podcast discussion was DuraGraft, which is the company’s ground-breaking flagship technology that offers a clinically-superior innovation to improve patient outcomes as well as cost efficiency associated with cardiac care, with further applications such as organ transplantation on the horizon. Recently…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.